Plasma Level of BACE1: The results of this study showed a significant difference between the plasma levels of BACE1 in patients with AD (27±7.4 pg/mL) compared with those in healthy controls (8±2.6 pg/mL) (p<0.01). This evidence concerns the gene BACE1 and Alzheimer disease.